Company news
Nuvo Pharmaceuticals Inc news in 2010
Nuvo Pharmaceuticals Inc's news releases, calls and decks from 2010, newest first.
Nuvo Research U.S. awarded US$1.3 million in research grants
November 10, 2010
Nuvo Research announces positive top-line WF10 Phase 2 trial results
November 8, 2010
Nuvo Research announces 2010 third quarter financial results
October 27, 2010
Notice of Nuvo research 2010 third quarter results conference call
October 20, 2010
Nuvo Research provides corporate update
September 7, 2010
Nuvo research to present at Rodman & Renshaw 12th annual healthcare conference
September 2, 2010
Nuvo Research announces 2010 second quarter financial results
July 29, 2010
Nuvo Research Inc. and Sprott Inc. Under Current Evaluation
July 22, 2010
Nuvo Research announces 2010 first quarter financial results
April 29, 2010
Nuvo Research announces U.S. availability of PENNSAID
April 27, 2010
Ubika Research has unveiled a new Small Cap Investment Idea for the week
April 22, 2010
Nuvo Research completes redemption of 5% convertible debentures
March 17, 2010
Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial
March 15, 2010
Nuvo Research announces 2009 fourth quarter and year-end financial results
February 19, 2010
Nuvo Research announces early redemption of 5% convertible debentures
February 4, 2010